EUVIMEDEUVIMED entdecken
Crossref

CRISPR-Corrected RPE Monolayer Patches for Geographic Atrophy in Age-Related Macular Degeneration: A Perspective

Maryam Ahmad Khan, Anam Haleem, Fahad Mushtaq, Ali Ahmed Khan, Neiha Khalid

INNOVAPATH · 24.03.2026 · 2 (1) · 6

DOI: 10.63501/w407zz65 ↗

Kurz gefasst

Fachartikel in der Zeitschrift INNOVAPATH, online erschienen am 24.03.2026. Verfasst von Maryam Ahmad Khan und 4 weiteren Autor:innen. Die Arbeit nennt 11 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Geographic atrophy (GA), the atrophic late-stage form of age-related macular degeneration (AMD), is a leading cause of irreversible central vision loss in older adults and lacks broadly restorative therapies. Recent advances in tissue engineering have produced polarized, scaffold-supported retinal pigment epithelium (RPE) monolayer patches that can be surgically implanted into GA lesions and show safety and early signs of anatomical and functional benefit (1,2,3). Concurrently, CRISPR-based genome editing (including base and prime editors) has matured to the point where disease-associated alleles and maladaptive pathways implicated in AMD (complement dysregulation, oxidative stress, lipid processing, ARMS2/HTRA1 locus effects) can be corrected or modulated in patient-derived induced pluripotent stem cells (iPSCs) with increasing precision (8,9,10). Integrating CRISPR correction into an autologous iPSC-RPE patch strategy promises a dual-action therapy: (a) structural replacement of lost RPE and restoration of a polarized monolayer niche and (b) reduction of cell-intrinsic susceptibility to AMD pathology by editing high-impact alleles or tuning pathogenic pathways. This Perspective outlines the biological rationale, a pragmatic GMP-compatible manufacturing and QC pipeline, preclinical evaluation milestones, clinical endpoints, key technical and regulatory challenges, and proposed mitigations to accelerate safe translation of CRISPR-corrected RPE monolayer patches from bench to first-in-human studies.

Zitieren

APA

Khan, M. A., Haleem, A., Mushtaq, F., Khan, A. A., & Khalid, N. (2026). CRISPR-Corrected RPE Monolayer Patches for Geographic Atrophy in Age-Related Macular Degeneration: A Perspective. INNOVAPATH, 2(1), 6. https://doi.org/10.63501/w407zz65

Vancouver

Khan MA, Haleem A, Mushtaq F, Khan AA, Khalid N. CRISPR-Corrected RPE Monolayer Patches for Geographic Atrophy in Age-Related Macular Degeneration: A Perspective. INNOVAPATH. 2026;2(1):6. doi:10.63501/w407zz65

BibTeX
@article{Khan2026,
  author = {Khan, Maryam Ahmad and Haleem, Anam and Mushtaq, Fahad and Khan, Ali Ahmed and Khalid, Neiha},
  title = {CRISPR-Corrected RPE Monolayer Patches for Geographic Atrophy in Age-Related Macular Degeneration: A Perspective},
  journal = {INNOVAPATH},
  year = {2026},
  volume = {2},
  number = {1},
  pages = {6},
  doi = {10.63501/w407zz65}
}
Kostenlos starten →